Successful Treatment of a Newborn With Acute Myocardial Infarction on the First Day of Life

Cesna, S.; Eicken, A.; Juenger, H.; Hess, J.
December 2013
Pediatric Cardiology;Dec2013, Vol. 34 Issue 8, p1868
Academic Journal
Case Study
Cardiogenic shock occurring after acute neonatal myocardial infarction (MI) due to coronary artery thrombosis is very rarely encountered. Acute neonatal MI typically presents suddenly with usually a fatal outcome. Treatment options in patients with this condition are limited. There are previous case reports in the literature advocating the use of extracorporeal membrane oxygenation for hemodynamic support. In this report, we present a newborn with severe MI secondary to thrombus formation within the left anterior descending coronary artery. There also proved to be a Factor V Leiden heterozygotic mutation. The patient initially presented with cardiogenic shock. After resuscitation and thrombolytic therapy were administered, coronary artery patency was restored resulting in myocardial revitalization and recovery of left-ventricular function within 4 weeks.


Related Articles

  • Clinical Implication of Cough CPR in Cardiac Cath Lab. Raut, Monish S.; Maheshwari, Arun // Indian Anaesthetists' Forum;Feb2013, Vol. 14 Issue 2, p1 

    A 60 year-old-male with inferoposterior ST-elevation myocardial infarction (STEMI) was shifted to cardiac cath lab for primary percutaneous coronary intervention (PCI). Coronary angiography revealed right coronary artery (RCA) dominance with complete occlusion of the RCA in mid vessel. During...

  • Rituximab induced myocardial infarction: A fatal drug reaction. Arunprasath, Palamalai; Gobu, Pakkirisamy; Dubashi, Biswajit; Satheesh, Santhosh; Balachander, Jayaraman // Journal of Cancer Research & Therapeutics;Jul-Sep2011, Vol. 7 Issue 3, p346 

    The article presents a case study of a 60-year-old diabetic man who was diagnosed with testicular lymphoma and had a high orchidectomy. He showed a fatal drug infusion reaction that developed an acute myocardial infaction after rituximab therapy for his testicular lymphoma treatment. He was...

  • Cardiac MRI of Lyme disease myocarditis. Maher, Ben; Murday, David; Harden, Stephen P. // Heart;Feb2012, Vol. 98 Issue 3, p264 

    The article presents a case study of a 41-year-old man with chest pain and flu-like illness. He was diagnosed with myocardial infarction and was administered with intravenous thrombolysis. Lyme serology confirmed the diagnosis. Also discussed are systematic manifestations of Lyme disease and the...

  • New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction. Armstrong, Paul W. // CMAJ: Canadian Medical Association Journal;9/18/2001, Vol. 165 Issue 6, p791 

    Presents a study of fibrinolytic therapy for acute ST-segment elevation myocardial infarction. Presentation of a case in which an elderly woman was admitted following the onset of crushing retrosternal chest pain; Pharmacologic characteristics; Clinical application; Concomitant therapy;...

  • The incremental value of myocardial contrast echocardiography (MCE) as a bedside decision-making tool in the coronary care unit. Winter, R; Willenheimer, R // European Journal of Echocardiography;2003, Vol. 5 Issue 2, p149 

    The article presents a case study of a 47-year-old man who has a developing acute myocardial infarction (MI) and bundle branch block. The study uses the myocardial contrast echocardiography (MCE) to predict its value as a decision-making tool in the coronary care unit. Results show the...

  • Acute Promyelocytic Leukemia as a Cause of Intracoronary Drug-Eluting--Stent Thrombosis. Sargsyan, Zaven; Higgins, Christopher; Alexandrescu, Sanda; Ott, David A.; Jain, Surendra K. // Texas Heart Institute Journal;2012, Vol. 39 Issue 3, p416 

    Stent thrombosis is a potentially lethal complication of percutaneous coronary intervention. We describe the case of a 51-year-old man who presented with acute anterior ST-segment-elevation myocardial infarction and underwent successful percutaneous transluminal coronary angioplasty and...

  • Study: Don't deny thrombolysis because of age, bleeding.  // Geriatrics;Jan94, Vol. 49 Issue 1, p57 

    Presents a study which shows that the routine practice of denying thrombolytic therapy to patients because of age or the presence of an active ulcer or other bleeding problems needs to be reconsidered. Decreased inhospital mortality; Patients analyzed in the research; Other aspects of the...

  • Benefits of thrombolysis last at least 5 years in MI patients.  // Geriatrics;Jan96, Vol. 51 Issue 1, p88 

    Looks at the benefits of thrombolytic therapy for Myocardial infarction (MI) patients. What systematic immediate angioplasty provides; Findings from analysis; Prognosis for a five year patient.

  • MI patients with normal exercise tests need no further...  // Geriatrics;Jan96, Vol. 51 Issue 1, p88 

    States that Myocardial infarction (MI) patients in the pre-thrombolytic era, and thrombolysed patients who respond normally to post-MI exercise have an excellent 6 month prognosis. Information on study done; Number of patients involved; Findings from study; What is post-MI angina.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics